Sun Pharmaceutical Industries LtdSUNPHARMA:NSI

Add to portfolio
Set alert
Interactive chart
Historical prices
Data definitions
1,006
4.10 / 0.41%
1.27m
76.46%
0.5056
Close in INRToday's changeShares traded1 year changeBeta
As of May 23 2013 11:20 BST.Data delayed by at least 15 minutes.

Interactive chart

Summary

Sun Pharmaceutical Industries Ltd (SUNPHARMA:NSI) set a new 52-week high during today's trading session when it reached 1,016.5. Over this period, the share price is up 75.94%.

52-week range
Today
553.00
Jun 05 2012
1,016.5
May 23 2013
Open980.00
Day high1,016.5
Day low980.00
Bid1,006
Offer0.00
Previous close1,001.9
Average volume866.99k
Shares outstanding1.04bn
Free float385.71m
P/E (TTM)36.74
Market cap1.04tn INR
EPS (TTM)27.27 INR
Annual div (TTM)4.25 INR
Annual div yield (TTM)0.42%
Div ex-dateAug 14 2012
Div pay-dateSep 09 2012

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Sun Pharmaceutical Industries Ltd+3.87%+5.78%+44.96%+76.46%+280.63%
CNX NIFTY IDX-3.29%+2.23%+6.03%+23.40%+20.63%
IN/HEALTH CARE-1.80%+4.97%+17.31%+26.76%--
IN/PHARMACEUTICALS-1.27%+5.48%+18.77%+28.05%--
As of May 23 2013 11:20 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.